Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Nuformix PLC (NFXN)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.2200 -0.0050    -2.70%
08:10:00 - Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 112,466
  • Bid/Ask: 0.1800 / 0.2200
  • Day's Range: 0.1800 - 0.1800
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BYW79Y38 
SEDOL:  BYW79Y3
Nuformix 0.2200 -0.0050 -2.70%

NFXN Recent Sentiments

 
User's sentiments regarding Nuformix shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect NFXN shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Nuformix.
Start Date Username Call Open Rate End Date Chg. %
Mar 07, 2024 Darren Price   0.2300 Mar 29, 2024 @ 0.1900 -17.39%
Mar 05, 2024 Bill Moc   0.1900 Mar 29, 2024 @ 0.1900 0.00%
Mar 01, 2024 Bill Moc   0.1965 Mar 05, 2024 @ 0.1900 -3.31%
Feb 19, 2024 Bill Moc   0.2726 Mar 01, 2024 @ 0.1965 +27.92%
Jan 08, 2024 Chris Kasapi   0.4400 Feb 02, 2024 @ 0.3000 -31.82%
Jan 03, 2024 Bill Moc   0.2900 Jan 16, 2024 @ 0.4400 -51.72%
Dec 07, 2023 Bill Moc   0.2950 Dec 29, 2023 @ 0.3250 -10.17%
Oct 09, 2023 Bill Moc   0.2578 Nov 30, 2023 @ 0.2725 +5.70%
Oct 06, 2023 iqbal HUSSAIN   0.2600 Nov 30, 2023 @ 0.2725 +4.81%
Sep 13, 2023 Suhar Yanto   0.2556 Nov 30, 2023 @ 0.2725 +6.61%
Jun 28, 2023 Spyros Tsil   0.2424 Nov 30, 2023 @ 0.2725 -12.42%
Jun 09, 2023 Adrian Hampshire   0.2900 Sep 01, 2023 @ 0.2892 -0.28%
May 22, 2023 warren olding   0.2900 Nov 30, 2023 @ 0.2725 -6.03%
Mar 13, 2023 Adrian Hampshire   0.3140 Apr 07, 2023 @ 0.3000 -4.46%
Mar 08, 2023 Haidar Razzak   0.3444 Mar 31, 2023 @ 0.3100 -9.99%
Mar 01, 2023 Darren Price   0.3255 Mar 24, 2023 @ 0.3250 -0.15%
Feb 01, 2023 Adrian Hampshire   0.3090 Feb 24, 2023 @ 0.2875 -6.96%
Dec 06, 2022 Adrian Hampshire   0.3474 Dec 07, 2022 @ 0.3600 +3.63%
Nov 17, 2022 Shibbi Ali   0.3623 Dec 09, 2022 @ 0.3550 +2.01%
Nov 10, 2022 gajie mo   0.4850 Dec 02, 2022 @ 0.3650 -24.74%
Nov 10, 2022 Shibbi Ali   0.5200 Nov 17, 2022 @ 0.3623 -30.33%
Oct 19, 2022 Adrian Hampshire   0.3744 Nov 11, 2022 @ 0.3944 +5.34%
Oct 05, 2022 Thelma Jay   0.3465 Oct 10, 2022 @ 0.3750 +8.23%
Sep 21, 2022 Adrian Hampshire   0.5475 Oct 14, 2022 @ 0.4000 -26.94%
Sep 21, 2022 Adrian Hampshire   0.5475 Sep 21, 2022 @ 0.5475 0.00%
Jul 12, 2022 Criss Cross   0.4220 Jul 18, 2022 @ 0.3500 -17.06%
Jul 07, 2022 Adrian Hampshire   0.3825 Jul 23, 2022 @ 0.5000 +30.72%
May 31, 2022 Joe Higashi   0.4493 Jun 06, 2022 @ 0.4100 -8.75%
May 30, 2022 Adrian Hampshire   0.5760 Jun 24, 2022 @ 0.3650 -36.63%
May 05, 2022 Adrian Hampshire   0.9210 May 30, 2022 @ 0.8600 -6.62%
Apr 05, 2022 Adrian Hampshire   0.9249 Apr 29, 2022 @ 0.9550 +3.25%
Mar 25, 2022 Darren Price   1.0098 Apr 21, 2022 @ 0.9500 -5.92%
Mar 22, 2022 Nasimi Jafarov   0.9300 Apr 21, 2022 @ 0.9500 +2.15%
Feb 25, 2022 Adrian Hampshire   1.1300 Mar 18, 2022 @ 0.9500 -15.93%
Feb 11, 2022 Samir samson   1.4140 Mar 04, 2022 @ 0.9500 -32.81%
Feb 10, 2022 Ambitive786   1.6000 Feb 14, 2022 @ 1.1000 -31.25%
Jan 27, 2022 Adrian Hampshire   1.2250 Feb 11, 2022 @ 1.5000 +22.45%
Jan 05, 2022 Darren Price   1.2200 Jan 28, 2022 @ 1.2000 -1.64%
Jan 04, 2022 Nasimi Jafarov   1.2000 Jan 28, 2022 @ 1.2000 0.00%
Nov 25, 2021 Chris Kasapi   1.6749 Dec 17, 2021 @ 1.0750 -35.82%
Nov 08, 2021 Ambitive786   1.7999 Dec 03, 2021 @ 1.5000 -16.66%
Oct 20, 2021 Adrian Hampshire   1.1666 Oct 21, 2021 @ 1.2900 +10.58%
Oct 12, 2021 Chris Marsden   1.1924 Nov 05, 2021 @ 1.7678 -48.26%
Aug 19, 2021 Tomislav Murk   1.4180 Sep 10, 2021 @ 1.4500 +2.26%
Aug 10, 2021 Richard Stevens   1.5500 Sep 03, 2021 @ 1.4000 -9.68%
Aug 02, 2021 Joe Higashi   1.5400 Aug 09, 2021 @ 1.4805 -3.86%
Jul 22, 2021 Steve Holland   1.6200 Aug 13, 2021 @ 1.5500 -4.32%
Jun 28, 2021 Marvin Patterson   2.1200 Jul 23, 2021 @ 1.6100 -24.06%
Jun 21, 2021 Richard Stevens   2.3400 Jul 16, 2021 @ 1.8500 -20.94%
Jun 07, 2021 Michael Buckley   2.1400 Jul 02, 2021 @ 2.0000 -6.54%
More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NFXN Price Commentary

Write your thoughts about Nuformix PLC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Hargreaves Smyth
Hargreaves Smyth Nov 10, 2022 9:03
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
low risk now, 3 mill mcap to 328mill yeah ill take that thanks when we get that order in within the next month or so. Take a look at the new presentation, its excellent, shows how much we are worth on first order, and we will get offers by the sound of it. Every faith in Dan, what a man!
Reply
0 0
Report
Criss Cross
Criss Cross Jul 12, 2022 8:25
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think this is one of those shares that fell to its bottom, made progress and now has everyone's interest again. I think it is set to bounce to 1.0 fairly easy then onward and upwards depending on the company. Last raise was December and the presentation is on 22 September so Id expect good investment from there on in . RNS Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, is pleased to announce that both of the abstracts submitted for presentation at the European Respiratory Society ("ERS") International Congress 2022 in Barcelona on September 4-6, on its lead asset NXP002, have been peer-reviewed and accepted for presentation. NXP002 is a potential novel inhaled treatment for Idiopathic Pulmonary Fibrosis ("IPF"). Commenting, Dr Julian Gilbert, Non-executive Director of Nuformix, said: "We believe NXP002 offers tremendous potential as a novel inhaled treatment for IPF and potentially other fibrosing interstitial lung diseases ("ILDs"). The Company is progressing a pre-clinical programme to demonstrate how its proprietary new form of tranilast can down regulate fibrosis and inflammation following inhalation, whilst avoiding severe side effects, which are key issues in the treatment of IPF and other ILDs. We are therefore delighted that the abstracts describing our initial work have been accepted following peer review. Now, sounds better than good!!!
Reply
2 0
Report
Richard Stevens
Richard Stevens Aug 10, 2021 12:57
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
100% Bullish Here
Reply
3 2
Report
Richard Stevens
Richard Stevens Jan 29, 2020 18:18
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Strong buy...so much positive news. due q1
Reply
5 5
Report
Horun Meaj
Horun Meaj Jan 29, 2020 18:18
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What news? Never came...
Reply
2 1
Report
Dean Grande
Dean Grande Sep 06, 2019 9:21
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Nice to see a positive rns onwards and upwards
Reply
1 2
Report
Andrew Robertson
Andrew Robertson Jun 24, 2019 9:17
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
much more to come. Hold for next waves. sales news and other milestones such as NX0002
Reply
6 0
Report
Adrian Hampshire
Adrian Hampshire Apr 26, 2019 13:12
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This could seriously do multiples of current SP.
Reply
6 2
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email